Key result
Goal-directed fluid therapy reduced the incidence of postoperative gastrointestinal dysfunction and shortened the length of hospital stay compared to conventional fluid therapy.
Why the study?
Postoperative gastrointestinal dysfunction causes delayed hospital stay after abdominal surgery, but evidence for the beneficial effects of goal-directed fluid therapy on gastrointestinal recovery remains controversial.
Does goal-directed fluid therapy reduce postoperative gastrointestinal dysfunction in adult patients undergoing major abdominal oncologic surgery?
RCT (n=100)
Partly blinded (patients and postoperative assessors blinded)
1:1 allocation using a closed envelope system
No
Does goal-directed fluid therapy reduce postoperative gastrointestinal dysfunction in adult patients undergoing major abdominal oncologic surgery?
Goal-directed fluid therapy guided by SVV and CI significantly reduces postoperative gastrointestinal dysfunction and shortens hospital stay in patients undergoing major abdominal oncologic surgery.
Answers are grounded in this paper and cite their sources.
Supports GDFT adoption to lower POGD; confirms SVV/CI-guided benefit in major abdominal oncologic surgery.
Background and Objective Postoperative gastrointestinal dysfunction (POGD) is a leading cause of delayed hospital stay after abdominal surgery. Goal-directed fluid therapy (GDFT) may improve gastrointestinal (GI) function, but the evidence for beneficial effects of GDFT for recovery of GI function remains controversial. The aim of this study was to evaluate the effect of GDFT on the postoperative recovery of GI function and length of hospital stay in patients undergoing major abdominal oncologic surgery. Methods In this randomized, partly blinded, controlled trial, adult patients scheduled for elective major abdominal oncologic surgery with general anesthesia, were randomly divided into GDFT group where fluid management was guided by stroke volume variation (SVV) and cardiac output index (CI) and the control group where fluid infusion was given based on conventional fluid therapy. Postoperative GI function was evaluated by Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms (I-FEED) score system and I-FEED score ≥ 6 was defined as POGD. Time to the first flatus, time to first tolerate oral diet and the length of hospital stay were recorded. Results One hundred patients completed the study protocol. Two of 50 patients (4%) developed POGD in the GDFT group, whereas POGD occurred in 16 of 50 patients (32%) in the control group ( P < 0.0001). GDFT significantly shorten time to first flatus by 11 hours [GDFT: 28.2 hours (9.2-48.0hours) versus Control: 39.4 hours (24.9–67.5 hours), P = 0.009] and time to first tolerate oral diet by 2 days [GDFT: 4.0 days (2.7-6.0 days) versus Control: 6.0 days (5.0-9.3days), P < 0.0001]. Moreover, the length of hospital stay was significantly shorter in GDFT group compared with the control group [GDFT: 9.0 days (5.8days) versus Control: 12.0 days (4.6days), P = 0.001]. Conclusions GDFT guided by SVV and CI could accelerate the postoperative recovery of GI function and shorten length of hospital stay following major abdominal oncologic surgery.
No takes yet. Share an insight, caveat, or question.
Yanxia et al. (2022) conducted an RCT in Major abdominal oncologic surgery (n=100). Goal-directed fluid therapy (GDFT) vs. Conventional fluid therapy was evaluated on Postoperative gastrointestinal dysfunction (POGD) (p=<0.0001). Goal-directed fluid therapy reduced the incidence of postoperative gastrointestinal dysfunction and shortened the length of hospital stay compared to conventional fluid therapy.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: